Patents by Inventor Elizabeth Klein
Elizabeth Klein has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20190310259Abstract: The present invention relates to the use of one or more biomarkers to evaluate the likelihood that a CDK4 inhibitor would produce an anti-cancer effect in a subject. Accordingly, in certain non-limiting embodiments, the present invention provides for methods, compositions and kits for a companion diagnostic for CDK4 inhibitors, and in particular, for the use of the colocalization of Enigma and CDH18 biomarkers to foci within the cancer for determining whether the cancer can be successfully treated by CDK4 inhibition.Type: ApplicationFiled: March 9, 2017Publication date: October 10, 2019Applicant: Memorial Sloan Kettering Cancer CenterInventors: Mary Elizabeth KLEIN, Marta KOVATCHEVA, Samuel SINGER, William D. TAP, Aimee CRAGO, Andrew KOFF
-
Publication number: 20190261888Abstract: A re-wearable wireless device configured to be attached to a user is disclosed. In some embodiments, the re-wearable wireless device includes a disposable component and a reusable component. The disposable component may include a first electrode, a second electrode, a cradle, and a battery. The cradle may include a first electrical connector, wherein the first electrical connector is electrically coupled to the first electrode, the second electrode, and the battery. The reusable component may include an electronics module, a housing configured to latch into the cradle, a second electrical connector, wherein the second electrical connector electrically couples the reusable component to the first electrode, the second electrode, and the battery. The re-wearable wireless device may be configured to detect a conductive electrical signal through the first electrode and the second electrode.Type: ApplicationFiled: May 7, 2019Publication date: August 29, 2019Inventors: Mark Zdeblick, Kien Lam, Jeremy Frank, Robert Azevedo, Elizabeth Klein, David O'Reilly, Aditya Dua, Joan Hain, Robert Leichner, Christopher Reggiardo, Lawrence Arne, Arna Ionescu Stoll, Kristin Pollock, Olivier Colliou, James Fish
-
Patent number: 9889135Abstract: The present invention relates to the use of one or more biomarkers to evaluate the likelihood that a CDK4 inhibitor would produce an anti-cancer effect in a subject. It is based, at least in part, on the discovery that cancer treatment with a CDK4 inhibitor is more effective where treated cancer cells undergo cellular senescence rather than a transient cell cycle arrest, where cellular senescence is associated with decreased MDM2 protein level. Accordingly, in non-limiting embodiments, the present invention provides for methods, compositions, and kits for a companion diagnostic for CDK4 inhibitors, and in particular, to the use of MDM2 expression as a biomarker for the likelihood that a cancer can be successfully treated by CDK4 inhibition.Type: GrantFiled: October 15, 2015Date of Patent: February 13, 2018Assignee: Memorial Sloan-Kettering Cancer CenterInventors: Andrew Koff, Aimee Crago, David Liu, Marta Kovatcheva, Samuel Singer, Gary K. Schwartz, Mark A. Dickson, Mary Elizabeth Klein
-
Publication number: 20160222131Abstract: The present invention relates to the use of one or more biomarkers to evaluate the likelihood that a CDK4 inhibitor would produce an anti-cancer effect in a subject. It is based, at least in part, on the discovery that cancer cells expressing ATRX prior to treatment are more likely to undergo cellular senescence in response to treatment with a CDK4 inhibitor. It is also based, at least in part, on the discovery that ATRX is phosphorylated in cancer cells that are not as responsive to CDK4 inhibitor therapy. Accordingly, in non-limiting embodiments, the present invention provides for methods, compositions, and kits for a companion diagnostic for CDK4 inhibitors, and in particular, to the use of ATRX expression as a biomarker for determining the likelihood that a cancer can be successfully and/or unsuccessfully treated by CDK4 inhibition.Type: ApplicationFiled: April 21, 2016Publication date: August 4, 2016Inventors: Andrew Koff, Marta Kovatcheva, Samuel Singer, John Petrini, Mary Elizabeth Klein
-
Publication number: 20160109430Abstract: The present invention provides assays for identifying drug candidates that regulate cellular senescence. In particular, the present invention relates to the use of ATRX foci as a biomarker for determining whether one or more drug candidates regulate senescence in a cell line. In one non-limiting embodiment, the present invention provides assays to identify compounds that can be used in a combinatorial cancer treatment. The present invention is based, at least in part, on the discovery that the number of ATRX foci increases in cells that undergo senescence. Accordingly, in non-limiting embodiments, the present invention provides for assays and kits for identifying drug combinations that may be useful in treating subject that have cancer and for identifying compounds that may be useful in treating age-related diseases.Type: ApplicationFiled: October 21, 2015Publication date: April 21, 2016Applicant: Memorial Sloan-Kettering Cancer CenterInventors: ANDREW KOFF, Marta Kovatcheva, Mary Elizabeth Klein
-
Publication number: 20160030433Abstract: The present invention relates to the use of one or more biomarkers to evaluate the likelihood that a CDK4 inhibitor would produce an anti-cancer effect in a subject. It is based, at least in part, on the discovery that cancer treatment with a CDK4 inhibitor is more effective where treated cancer cells undergo cellular senescence rather than a transient cell cycle arrest, where cellular senescence is associated with decreased MDM2 protein level. Accordingly, in non-limiting embodiments, the present invention provides for methods, compositions, and kits for a companion diagnostic for CDK4 inhibitors, and in particular, to the use of MDM2 expression as a biomarker for the likelihood that a cancer can be successfully treated by CDK4 inhibition.Type: ApplicationFiled: October 15, 2015Publication date: February 4, 2016Applicant: Memorial Sloan-Kettering Cancer CenterInventors: Andrew Koff, Aimee Crago, David Liu, Marta Kovatcheva, Samuel Singer, Gary K. Schwartz, Mark A. Dickson, Mary Elizabeth Klein
-
Patent number: 8429014Abstract: Methods and systems for providing advertising content over the Internet through a hierarchical content-specific node structure and pricing advertising delivery over each node independently. Independent delivery and pricing allows an advertiser to pay more for advertisements delivered to a narrowly targeted audience likely to be interested in the goods or services offered by the advertising entity and to pay less for advertisements directed at a more general audience who may or may not have an interest in the goods or services offered. The less content specific the node is, the less targeted the advertisement will be, and therefore, the less valuable the advertisement will be to the advertising entity. Targeted advertising to multiple levels of content specific nodes is enabled.Type: GrantFiled: June 25, 2010Date of Patent: April 23, 2013Assignee: Google Inc.Inventors: Christopher J. Barry, Eric Robert Bronnimann, Jacob Paul Ewerdt, William C. Day, Kevin R J B Donovan, Brian Hammond, Elizabeth Klein, Matthew Gordon Knell, Ron McCoy, Sara Frances Plath, Dan C. Porter, Eric Christopher Saam
-
Publication number: 20100332321Abstract: Methods and systems for providing advertising content over the Internet through a hierarchical content-specific node structure and pricing advertising delivery over each node independently. Independent delivery and pricing allows an advertiser to pay more for advertisements delivered to a narrowly targeted audience likely to be interested in the goods or services offered by the advertising entity and to pay less for advertisements directed at a more general audience who may or may not have an interest in the goods or services offered. The less content specific the node is, the less targeted the advertisement will be, and therefore, the less valuable the advertisement will be to the advertising entity. Targeted advertising to multiple levels of content specific nodes is enabled.Type: ApplicationFiled: June 25, 2010Publication date: December 30, 2010Applicant: GOOGLE INC.Inventors: Christopher J. Barry, Eric Robert Bronnimann, Jacob Paul Ewerdt, William C. Day, Kevin R.J.B Donovan, Brian Hammond, Elizabeth Klein, Matthew Gordon Knell, Ron McCoy, Sara Frances Plath, Dan C. Porter, Eric Christopher Saam
-
Patent number: 7752073Abstract: Methods and systems for providing advertising content over the Internet through a hierarchical content-specific node structure and pricing advertising delivery over each node independently. Independent delivery and pricing allows an advertiser to pay more for advertisements delivered to a narrowly targeted audience likely to be interested in the goods or services offered by the advertising entity and to pay less for advertisements directed at a more general audience who may or may not have an interest in the goods or services offered. The less content specific the node is, the less targeted the advertisement will be, and therefore, the less valuable the advertisement will be to the advertising entity. Targeted advertising to multiple levels of content specific nodes is enabled.Type: GrantFiled: October 19, 2005Date of Patent: July 6, 2010Assignee: Google Inc.Inventors: Christopher J. Barry, Eric Robert Bronnimann, Jacob Paul Ewerdt, William C. Day, Kevin R J B Donovan, Brian Hammond, Elizabeth Klein, Matthew Gordon Knell, Ron McCoy, Sara Frances Plath, Dan C. Porter, Eric Christopher Saam
-
Patent number: 7752072Abstract: Methods and systems for providing advertising content over the Internet through a hierarchical content-specific node structure and pricing advertising delivery over each node independently. Independent delivery and pricing allows an advertiser to pay more for advertisements delivered to a narrowly targeted audience likely to be interested in the goods or services offered by the advertising entity and to pay less for advertisements directed at a more general audience who may or may not have an interest in the goods or services offered. The less content specific the node is, the less targeted the advertisement will be, and therefore, the less valuable the advertisement will be to the advertising entity. Targeted advertising to multiple levels of content specific nodes is enabled.Type: GrantFiled: December 4, 2002Date of Patent: July 6, 2010Assignee: Google Inc.Inventors: Christopher J. Barry, Eric Robert Bronnimann, Jacob Paul Ewerdt, William C. Day, Kevin R J B Donovan, Brian Hammond, Elizabeth Klein, Matthew Gordon Knell, Ron McCoy, Sara Frances Plath, Dan C. Porter, Eric Christopher Saam
-
Publication number: 20070260508Abstract: Methods and systems for providing advertising content over the Internet through a hierarchical content-specific node structure and pricing advertising delivery over each node independently. Independent delivery and pricing allows an advertiser to pay more for advertisements delivered to a narrowly targeted audience likely to be interested in the goods or services offered by the advertising entity and to pay less for advertisements directed at a more general audience who may or may not have an interest in the goods or services offered. The less content specific the node is, the less targeted the advertisement will be, and therefore, the less valuable the advertisement will be to the advertising entity. Targeted advertising to multiple levels of content specific nodes is enabled.Type: ApplicationFiled: October 19, 2005Publication date: November 8, 2007Inventors: Christopher Barry, Eric Bronnimann, Jacob Ewerdt, William Day, Kevin Donovan, Brian Hammond, Elizabeth Klein, Matthew Knell, Ron McCoy, Sara Plath, Dan Porter, Eric Saam
-
Publication number: 20060207624Abstract: This method for flawless application of nail polish is a simple four step processing involving the use of a water soluble facial masque, nail primer (if necessary) and running water.Type: ApplicationFiled: March 18, 2005Publication date: September 21, 2006Inventor: Elizabeth Klein
-
Publication number: 20040015397Abstract: Methods and systems for providing advertising content over the Internet through a hierarchical content-specific node structure and pricing advertising delivery over each node independently. Independent delivery and pricing allows an advertiser to pay more for advertisements delivered to a narrowly targeted audience likely to be interested in the goods or services offered by the advertising entity and to pay less for advertisements directed at a more general audience who may or may not have an interest in the goods or services offered. The less content specific the node is, the less targeted the advertisement will be, and therefore, the less valuable the advertisement will be to the advertising entity. Targeted advertising to multiple levels of content specific nodes is enabled.Type: ApplicationFiled: December 4, 2002Publication date: January 22, 2004Inventors: Christopher J. Barry, Eric Robert Bronnimann, Jacob Paul Ewerdt, William C. Day, Kevin RJB Donovan, Brian Hammond, Elizabeth Klein, Matthew Gordon Knell, Ron McCoy, Sara Frances Plath, Dan C. Porter, Eric Christopher Saam
-
Patent number: 6076195Abstract: An undergarment having front and rear portions attached together so as to define a waist opening in the top of the undergarment and a pair of leg openings in the opposite sides of the undergarment. A medial portion extends from the waist opening to a location between the leg openings. The medial portion has side and bottom edges attached to the front portion so as to define a pocket between the medial and front portions with a pocket opening in the top of the undergarment adjacent the waist opening. A bifurcated waistband has a circular, outer part which is attached to the front portion and the rear portion adjacent the waist opening. The waistband also has an inner part attached to the medial portion and the outer part.Type: GrantFiled: April 27, 1999Date of Patent: June 20, 2000Inventor: Karen Elizabeth Klein